Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 January 2024 | Story Gerda-Marié van Rooyen | Photo Chris Nelson
Dr Maryam Amra Jordaan
Dr Maryam Amra Jordaan, co-founded SA Rebuilders.

Only 16% of plastic gets recycled in South Africa, despite technological advancements. While the Extended Producer Responsibility (EPR) Regulation of 2021 assigns post-consumer recycling responsibility to producers, substantial efforts are needed to develop effective waste management strategies, heighten public awareness, discover practical solutions, and hold plastic-producing companies accountable.

Prioritising environmental sustainability

Dr Maryam Amra Jordaan co-founded SA Rebuilders with her husband, Yasar Amra, in 2016. By combining 3D printing, chemistry, and plastic recycling, they tackle socio-economic issues while prioritising environmental sustainability. As the daughter of a miner from Kimberley, Dr Jordaan is committed to mitigating the negative effects that industries have on the health, environment, and social aspects of local communities. She was honoured with an Alumni Cum Laude Award from the University of the Free State (UFS) for her work in this regard.

Dr Jordaan’s academic journey at the UFS from 2001 to 2013 includes a BSc in Chemistry and Physiology, BSc Honours, MSc, and a PhD in Organic Chemistry. She dedicated five years to lecturing and research on the Qwaqwa Campus and four years at the Mangosuthu University of Technology (MUT). During this time, she authored 19 pharmaceutical and environmental chemistry research papers and won numerous national and international awards. She entered the UFS with dreams of assisting in some way and ended up helping to solve the Sustainable Development Goals (SDGs).

“Remarkable potential for rapid prototyping and supply chain resilience through digitisation exists, but the current energy crisis hampers the full realisation of 3D printing’s potential,” Dr Jordaan explains. Added to this, is the complex endeavour of becoming a 3D engineer. “Expertise in materials science and project management is equally essential. Creativity, quick learning, and meticulous attention to detail are all characteristics necessary to excel as a 3D engineer.”

Seeking out biodegradable product alternatives

Dr Jordaan stresses the need for effective waste management, awareness, practical solutions, and accountability for individuals and plastic-producing companies. Therefore, she promotes reusable and recyclable shopping bags, among others, and instils this behaviour in her children. The Amras actively seek out biodegradable product alternatives, as they are fully aware of the environmental impact of the manufacturing industry.

They incorporated this ideology in the manufacturing process of organic butter by transforming the plastic waste from this process into a 3D filament. This product is currently undergoing SABS testing, after which it will be available to the local market.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept